Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.25.0.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Amortization $ 233,410 $ 375,821
Net operating loss carryforward 17,668,228 15,445,916
Allowance for doubtful accounts 393,001 387,818
Charitable contributions 644
Stock options 1,003,453
Accrued liabilities 5,121,508 1,826,839
HHS Provider Relief Funds 37,845 67,685
Employee retention credit 292,282
HTS and AMSG basis difference 878,709
Deferred state tax asset 4,043,616 4,089,682
Total deferred income tax assets 27,497,608 24,368,849
Right-of-use asset (93,875)
Depreciation (670,176) (583,812)
Deferred tax asset, net 26,733,557 23,785,037
Less: valuation allowance (26,733,557) (23,785,037)
Net deferred tax assets